Epione Biopharmaceuticals and Owen Mumford of England began talks on providing a version of their pre-certified Autopen for use in Epione Biopharmaceutical’s injectable drug candidate for Abortive Migraine Relief.
ABOUT OWEN MUMFORD
Owen Mumford has been at the forefront of medical device innovation for over 60 years, creating solutions that improve the delivery of healthcare and home health treatments for people around the world. Their products span devices that make blood testing more comfortable to solutions that make it easier to administer life-saving medication.
Their experience in medical devices began in the 1950s when founders Ivan Owen and John Mumford established the company. Today, they have direct sales offices and a network of distribution partners serving customers in over 60 countries, and employ over 700 people across the Americas, Europe and Asia.